{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:56:02Z","timestamp":1784152562312,"version":"3.55.0"},"publisher-location":"Cham","reference-count":55,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031871665","type":"print"},{"value":"9783031871672","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/82_2024_276","type":"book-chapter","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T09:04:12Z","timestamp":1723280652000},"page":"185-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HemoClear: A Practical and Cost-Effective Alternative to Conventional Convalescent Plasma Retrieval Methods"],"prefix":"10.1007","author":[{"given":"Arno","family":"Nierich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Bihariesingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bansie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,11]]},"reference":[{"key":"276_CR1","unstructured":"Aleccia J (2021) The hype has faded, but don\u2019t count out convalescent plasma in Covid battle. KHN News 1\u20136. Available from: https:\/\/khn.org\/news\/article\/convalescent-plasma-covid-battle-super-donors\/"},{"key":"276_CR2","doi-asserted-by":"crossref","unstructured":"Allahyari A, Seddigh-Shamsi M, Mahmoudi M, Amel Jamehdar S, Amini M, Mozdourian M et al (2021) Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome. Int Immunopharmacol 93:107239. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920337061","DOI":"10.1016\/j.intimp.2020.107239"},{"key":"276_CR3","doi-asserted-by":"crossref","unstructured":"Amenge J, Scherphof S, Osemwengie D, Nierich A, Lagerberg JW (2022) Comparison of washing efficiency and recovery of blood cells between centrifugation, coarse filtration and microfiltration techniques to prepare autologous blood for transfusion. J Blood Med 13:549\u2013558. Available from: https:\/\/www.dovepress.com\/comparison-of-washing-efficiency-and-recovery-of-blood-cells-between-c-peer-reviewed-fulltext-article-JBM","DOI":"10.2147\/JBM.S367918"},{"key":"276_CR4","doi-asserted-by":"crossref","unstructured":"Bacal CJO, Maina JW, Nandurkar HH, Khaleel M, Guijt R, Chang Y et al (2021) Blood apheresis technologies\u2014a critical review on challenges towards efficient blood separation and treatment. Mater Adv 2(22):7210\u20137236. Available from: http:\/\/xlink.rsc.org\/?DOI=D1MA00859E","DOI":"10.1039\/D1MA00859E"},{"key":"276_CR5","doi-asserted-by":"publisher","unstructured":"Barro L, Burnouf PA, Chou ML, Nebie O, Wu YW, Chen MS et al (2021) Human platelet lysates for human cell propagation. Platelets 32(2):152\u2013162. https:\/\/doi.org\/10.1080\/09537104.2020.1849602","DOI":"10.1080\/09537104.2020.1849602"},{"key":"276_CR6","doi-asserted-by":"publisher","unstructured":"Behring H, Kitasato H (1890) Ueber das Zustandekommen der Diphtherie-Immunit\u00e4t und der Tetanus-Immunit\u00e4t bei Thieren. DMW - Dtsch Medizinische Wochenschrift 16(49):1113\u20131114. https:\/\/doi.org\/10.1055\/s-0029-1207589","DOI":"10.1055\/s-0029-1207589"},{"key":"276_CR7","doi-asserted-by":"crossref","unstructured":"Bihariesingh R, Bansie R, Fr\u00f6berg J, Ramdhani N, Mangroo R, Bustamente D et al (2021) Mortality reduction in ICU-admitted COVID-19 patients in suriname after treatment with convalescent plasma acquired via gravity filtration. Anesth Clin Res 2(2):1\u201312. Available from: https:\/\/www.sciencerepository.org\/mortality-reduction-in_ACR-2021-2-103","DOI":"10.31487\/j.ACR.2021.02.03"},{"key":"276_CR8","doi-asserted-by":"publisher","unstructured":"Bihariesingh-Sanchit R, Bansie R, Ramdhani N, Mangroo R, Bustamente D, Diaz E et al (2023) Reduced mortality among COVID-19 ICU patients after treatment with hemoclear convalescent plasma in Suriname. Casadevall A, editor. MBio 14(2). https:\/\/doi.org\/10.1128\/mbio.03379-22","DOI":"10.1128\/mbio.03379-22"},{"key":"276_CR9","doi-asserted-by":"crossref","unstructured":"Bihariesingh-Sanchit R, Bansie R, Sam STA, Lieveld C, Simons A, Kromosoeto J et al (2024) Gravity-driven crossflow membrane filtration and mechanical centrifugation yield plasma with equivalent total and COVID-19-specific immunoglobulin content. World J Adv Res Rev 21(02):1107\u20131115. Available from: https:\/\/wjarr.com\/sites\/default\/files\/WJARR-2024-0527.pdf","DOI":"10.30574\/wjarr.2024.21.2.0527"},{"key":"276_CR10","doi-asserted-by":"crossref","unstructured":"Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL et al (2020) Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest 130(6):2757\u20132765. http:\/\/www.jci.org\/articles\/view\/138745","DOI":"10.1172\/JCI138745"},{"key":"276_CR11","doi-asserted-by":"crossref","unstructured":"Bloch EM, Goel R, Montemayor C, Cohn C, Tobian AAR (2021) Promoting access to COVID-19 convalescent plasma in low- and middle-income countries. Transfus Apher Sci 60(1):102957. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220302731","DOI":"10.1016\/j.transci.2020.102957"},{"issue":"3","key":"276_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/voxs.12415","volume":"13","author":"T Burnouf","year":"2018","unstructured":"Burnouf T (2018) Multifaceted regenerative lives of \u2018expired\u2019 platelets. ISBT Sci Ser 13(3):323\u2013330","journal-title":"ISBT Sci Ser"},{"key":"276_CR13","doi-asserted-by":"publisher","unstructured":"Burnouf T, Goubran HA (2022) Regenerative effect of expired platelet concentrates in human therapy: an update. Transfus Apher Sci 61(1):103363. https:\/\/doi.org\/10.1016\/j.transci.2022.103363","DOI":"10.1016\/j.transci.2022.103363"},{"key":"276_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.69866","volume":"10","author":"A Casadevall","year":"2021","unstructured":"Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS et al (2021) Convalescent plasma use in the usa was inversely correlated with covid-19 mortality. Elife 10:1\u201314","journal-title":"Elife"},{"key":"276_CR15","doi-asserted-by":"crossref","unstructured":"Casadevall A, Scharff MD (1995) Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis 21:150\u2013161. Available from: https:\/\/academic.oup.com\/cid\/article\/21\/1\/150\/402600","DOI":"10.1093\/clinids\/21.1.150"},{"key":"276_CR16","doi-asserted-by":"publisher","unstructured":"Delamou A, Haba NY, Mari-Saez A, Gallian P, Ronse M, Jacobs J et al (2016) Organizing the donation of convalescent plasma for a therapeutic clinical trial on ebola virus disease: the experience in guinea. Am J Trop Med Hyg 95(3):647\u2013653. https:\/\/doi.org\/10.4269\/ajtmh.15-0890","DOI":"10.4269\/ajtmh.15-0890"},{"issue":"3","key":"276_CR17","first-page":"1","volume":"9","author":"DR Delgado","year":"2020","unstructured":"Delgado DR, Romero E (2020) A comparative analysis between nanomembrane-based therapeutic plasmapheresis and other plasmapheresis methods and their potential use during the COVID-19 pandemic. Altern Integr Med 9(3):1\u20135","journal-title":"Altern Integr Med"},{"key":"276_CR18","doi-asserted-by":"publisher","unstructured":"Edwards T, Semple MG, De Weggheleire A, Claeys Y, De Crop M, Menten J et al (2016) Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014\u20132015 outbreak. Clin Trials J Soc Clin Trials 13(1):13\u201321. https:\/\/doi.org\/10.1177\/1740774515621056","DOI":"10.1177\/1740774515621056"},{"key":"276_CR19","doi-asserted-by":"crossref","unstructured":"Finland M (1982) Gaps in therapy for infectious diseases: a historical perspective. J Infect Dis 145(3):401\u2013407. Available from: http:\/\/www.jstor.org\/stable\/30109497","DOI":"10.1093\/infdis\/145.3.401"},{"key":"276_CR20","doi-asserted-by":"publisher","unstructured":"Focosi D, Anderson AO, Tang JW, Tuccori M (2020) Convalescent plasma therapy for COVID-19: state of the art. Clin Microbiol Rev 33(4). https:\/\/doi.org\/10.1128\/CMR.00072-20","DOI":"10.1128\/CMR.00072-20"},{"key":"276_CR21","doi-asserted-by":"crossref","unstructured":"Focosi D, Anderson AO, Tang JW, Tuccori M (2020) Convalescent plasma therapy for COVID-19: state of the art. Clin Microbiol Rev 33(4). Available from: https:\/\/cmr.asm.org\/content\/33\/4\/e00072-20","DOI":"10.1128\/CMR.00072-20"},{"key":"276_CR22","doi-asserted-by":"publisher","unstructured":"Garraud O, Heshmati F, Pozzetto B, Lefrere F, Girot R, Saillol A et al (2016) Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow. Transfus Clin Biol 23(1):39\u201344. https:\/\/doi.org\/10.1016\/j.tracli.2015.12.003","DOI":"10.1016\/j.tracli.2015.12.003"},{"key":"276_CR23","doi-asserted-by":"publisher","unstructured":"Gifford SC, Strachan BC, Xia H, V\u00f6r\u00f6s E, Torabian K, Tomasino TA et al (2018) A portable system for processing donated whole blood into high quality components without centrifugation. B\u00f6nig H, editor. PLoS One 13(1):e0190827. https:\/\/doi.org\/10.1371\/journal.pone.0190827","DOI":"10.1371\/journal.pone.0190827"},{"key":"276_CR24","doi-asserted-by":"publisher","unstructured":"van Griensven J, De Weiggheleire A, Delamou A, Smith PG, Edwards T, Vandekerckhove P et al (2016) The use of ebola convalescent plasma to treat ebola virus disease in resource-constrained settings: a perspective from the field. Clin Infect Dis 62(1):69\u201374. https:\/\/doi.org\/10.1093\/cid\/civ680","DOI":"10.1093\/cid\/civ680"},{"issue":"1","key":"276_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11255-015-1137-3","volume":"48","author":"C Hafer","year":"2016","unstructured":"Hafer C, Golla P, Gericke M, Eden G, Beutel G, Schmidt JJ et al (2016) Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study. Int Urol Nephrol 48(1):133\u2013138","journal-title":"Int Urol Nephrol"},{"key":"276_CR26","unstructured":"Health Technology Wales (2020) Convalescent plasma: a costing review"},{"key":"276_CR27","doi-asserted-by":"crossref","unstructured":"Hoetink A, Scherphof SF, Mooi FJ, Westers P, van Dijk J, van de Leur SJ et al (2020) An in vitro pilot study comparing the novel HemoClear gravity-driven microfiltration cell salvage system with the conventional centrifugal XTRATM autotransfusion device. Anesthesiol Res Pract 2020:1\u201310. Available from: https:\/\/www.hindawi.com\/journals\/arp\/2020\/9584186\/","DOI":"10.1155\/2020\/9584186"},{"key":"276_CR28","doi-asserted-by":"publisher","unstructured":"Ipe TS, Ugwumba B, Spencer HJ, Le T, Ridenour T, Armitage J et al (2022) Treatment of COVID-19 patients with two units of convalescent plasma in a resource-constrained state. Lab Med 1\u20136. https:\/\/doi.org\/10.1093\/labmed\/lmac055\/6623577","DOI":"10.1093\/labmed\/lmac055\/6623577"},{"key":"276_CR29","doi-asserted-by":"publisher","unstructured":"Jorda A, Kussmann M, Kolenchery N, Siller-Matula JM, Zeitlinger M, Jilma B et al (2022) Convalescent plasma treatment in patients with Covid-19: a systematic review and meta-analysis. Front Immunol 13:1\u20139. Available from: https:\/\/doi.org\/10.3389\/fimmu.2022.817829\/full","DOI":"10.3389\/fimmu.2022.817829\/full"},{"key":"276_CR30","unstructured":"Joyner MJ, Bruno KA, Klassen SA, Kunze KL, Johnson PW, Lesser ER et al (2020) Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc 95(9):1888\u20131897. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620306510"},{"key":"276_CR31","doi-asserted-by":"publisher","unstructured":"Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW et al (2021) Convalescent plasma antibody levels and the risk of death from Covid-19. N Engl J Med 384(11):1015\u20131027. https:\/\/doi.org\/10.1056\/NEJMoa2031893","DOI":"10.1056\/NEJMoa2031893"},{"issue":"12","key":"276_CR32","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1111\/trf.13850","volume":"56","author":"P Kes","year":"2016","unstructured":"Kes P, Janssens ME, Ba\u0161i\u0107-Juki\u0107 N, Kljak M (2016) A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures. Transfusion 56(12):3065\u20133072","journal-title":"Transfusion"},{"key":"276_CR33","doi-asserted-by":"publisher","unstructured":"Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S et al (2021a) The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis. Mayo Clin Proc 96(5):1262\u20131275. https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.008","DOI":"10.1016\/j.mayocp.2021.02.008"},{"key":"276_CR34","doi-asserted-by":"publisher","unstructured":"Klassen SA, Senefeld JW, Senese KA, Johnson PW, Wiggins CC, Baker SE et al (2021b) Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence. Front Med 8:2\u201310. https:\/\/doi.org\/10.3389\/fmed.2021.684151\/full","DOI":"10.3389\/fmed.2021.684151\/full"},{"issue":"1","key":"276_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/infdis\/jiaa673","volume":"223","author":"WT Lee","year":"2021","unstructured":"Lee WT, Girardin RC, Dupuis AP, Kulas KE, Payne AF, Wong SJ et al (2021) Neutralizing antibody responses in COVID-19 convalescent sera. J Infect Dis 223(1):47\u201355","journal-title":"J Infect Dis"},{"key":"276_CR36","doi-asserted-by":"crossref","unstructured":"Lee PI, Hsueh PR (2020) Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect","DOI":"10.1016\/j.jmii.2020.02.001"},{"key":"276_CR37","doi-asserted-by":"crossref","unstructured":"Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J et al (2020) Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19. JAMA 324(5):460. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2766943","DOI":"10.1001\/jama.2020.12607"},{"key":"276_CR38","doi-asserted-by":"publisher","unstructured":"Libster R, P\u00e9rez Marc G, Wappner D, Coviello S, Bianchi A, Braem V et al (2021) Early high-titer plasma therapy to prevent severe Covid-19 in older adults. N Engl J Med 384(7):610\u2013618. https:\/\/doi.org\/10.1056\/NEJMoa2033700","DOI":"10.1056\/NEJMoa2033700"},{"key":"276_CR39","doi-asserted-by":"publisher","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL (2006) Meta-analysis: convalescent blood products for spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145(8):599. https:\/\/doi.org\/10.7326\/0003-4819-145-8-200610170-00139","DOI":"10.7326\/0003-4819-145-8-200610170-00139"},{"key":"276_CR40","doi-asserted-by":"publisher","unstructured":"Muttamba W, Lusiba J, Namakula LO, Byakika-Kibwika P, Ssali F, Ddungu H et al (2021) Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda. Hosuru Subramanya S, editor. PLoS One 16(6):e0252306. https:\/\/doi.org\/10.1371\/journal.pone.0252306","DOI":"10.1371\/journal.pone.0252306"},{"key":"276_CR41","doi-asserted-by":"publisher","unstructured":"Natarajan H, Crowley AR, Butler SE, Xu S, Weiner JA, Bloch EM et al (2021) Markers of polyfunctional SARS-CoV-2 antibodies in convalescent plasma. Diamond MS, editor. MBio 12(2):1\u201314. https:\/\/doi.org\/10.1128\/mBio.00765-21","DOI":"10.1128\/mBio.00765-21"},{"issue":"1","key":"276_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.15562\/bmj.v12i1.3593","volume":"12","author":"E Noerwidayati","year":"2023","unstructured":"Noerwidayati E, Pribadi F (2023) An analysis of convalescent plasma unit cost calculation using time-driven activity-based costing (TDABC) method. Bali Med J. 12(1):331\u2013339","journal-title":"Bali Med J."},{"key":"276_CR43","doi-asserted-by":"publisher","unstructured":"Osemwengie D, Lagerberg JW, Vlaar R, Gouwerok E, Go M, Nierich AP et al (2022) Recovery of platelet\u2010rich red blood cells and acquisition of convalescent plasma with a novel gravity\u2010driven blood separation device. Transfus Med 32(1):53\u201363. https:\/\/doi.org\/10.1111\/tme.12830","DOI":"10.1111\/tme.12830"},{"key":"276_CR44","doi-asserted-by":"publisher","unstructured":"Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D et al (2020) Antibody response to SARS-CoV-2 infection in humans: a systematic review. PLoS One 15(12):1\u201327. https:\/\/doi.org\/10.1371\/journal.pone.0244126","DOI":"10.1371\/journal.pone.0244126"},{"issue":"3","key":"276_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000510983","volume":"50","author":"S Redant","year":"2021","unstructured":"Redant S, De Bels D, Ismaili K, Honor\u00e9 PM (2021) Membrane-based therapeutic plasma exchange in intensive care. Blood Purif 50(3):290\u2013297","journal-title":"Blood Purif"},{"key":"276_CR46","doi-asserted-by":"crossref","unstructured":"Salazar E, Christensen PA, Graviss EA, Nguyen DT, Castillo B, Chen J et al (2019) Significantly decreased mortality in a large cohort of coronavirus disease 2019 (COVID-19) patients transfused early with convalescent plasma containing high-titer anti\u2013severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein IgG. Am J Pathol 191(1):90\u2013107. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944020304892","DOI":"10.1016\/j.ajpath.2020.10.008"},{"key":"276_CR47","doi-asserted-by":"crossref","unstructured":"Selvi V (2020) Convalescent plasma: a challenging tool to treat COVID-19 patients\u2014a lesson from the past and new perspectives. Biomed Res Int 2020:1\u20138. Available from: https:\/\/www.hindawi.com\/journals\/bmri\/2020\/2606058\/","DOI":"10.1155\/2020\/2606058"},{"key":"276_CR48","doi-asserted-by":"publisher","unstructured":"Shen L, Wang C, Zhao J, Tang X, Shen Y, Lu M et al (2020) Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression. Emerg Microbes Infect 9(1):1096\u20131101. https:\/\/doi.org\/10.1080\/22221751.2020.1766382","DOI":"10.1080\/22221751.2020.1766382"},{"key":"276_CR49","unstructured":"Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG et al (2022) Early outpatient treatment for Covid-19 with convalescent plasma. N Engl J Med"},{"key":"276_CR50","doi-asserted-by":"publisher","unstructured":"Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y (2020) Collecting and evaluating convalescent plasma for COVID\u201019 treatment: why and how? Vox Sang 115(6):488\u2013494. https:\/\/doi.org\/10.1111\/vox.12926","DOI":"10.1111\/vox.12926"},{"key":"276_CR51","doi-asserted-by":"crossref","unstructured":"Tse P, Jamula E, Cook R, Fergusson D, Cushing M, Arnold D (2023) Cost-effectiveness of convalescent plasma for COVID-19\u202f: a cost-effectiveness analysis of the CONCOR-1 randomized trial","DOI":"10.21203\/rs.3.rs-3126221\/v1"},{"key":"276_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijid.2021.02.054","volume":"105","author":"A Tworek","year":"2021","unstructured":"Tworek A, Jaro\u0144 K, Uszy\u0144ska-Ka\u0142u\u017ca B, Rydzewski A, Gil R, Depta\u0142a A et al (2021) Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients\u2014propensity-score matched case-control study. Int J Infect Dis 105:209\u2013215","journal-title":"Int J Infect Dis"},{"key":"276_CR53","unstructured":"WHO Blood Regulators Network (2014) Position paper on collection and use of convalescent plasma or serum as an element in middle east respiratory syndrome coronavirus response [Internet]. WHO. Available from: http:\/\/www.who.int\/blood-products\/brn\/BRN_PositionPaperConvPlasmaMERSCoV_March2014.pdf"},{"issue":"1","key":"276_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2215\/CJN.04680513","volume":"9","author":"ME Williams","year":"2014","unstructured":"Williams ME, Balogun RA (2014) Principles of separation: indications and therapeutic targets for plasma exchange. Clin J Am Soc Nephrol 9(1):181\u2013190","journal-title":"Clin J Am Soc Nephrol"},{"key":"276_CR55","doi-asserted-by":"publisher","unstructured":"Xu X, Nie S, Wang Y, Long Q, Zhu H, Zhang X et al (2021) Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study. Signal Transduct Target Ther 6(1):197. https:\/\/doi.org\/10.1038\/s41392-021-00611-6","DOI":"10.1038\/s41392-021-00611-6"}],"container-title":["Current Topics in Microbiology and Immunology","Convalescent Plasma and Other Antibody Therapies for Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2024_276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:55:16Z","timestamp":1784109316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2024_276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031871665","9783031871672"],"references-count":55,"URL":"https:\/\/doi.org\/10.1007\/82_2024_276","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"11 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Dr. Nierich is the inventor of the HemoClear filter and holds stock ownership in HemoClear BV, Dr. Stolteweg 70, 8025 AZ Zwolle, Netherlands.The other authors have no conflicts to declare.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}